Last reviewed · How we verify
IMO-8400 Regimen 3
At a glance
| Generic name | IMO-8400 Regimen 3 |
|---|---|
| Sponsor | Idera Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |